Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
| No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
| 1 | Alcoholism |
[1] DRD2 | D01745 | Domperidone | [5] 6, 13, 17, 51, 230 |
| D07868 | |||||
| 2 | Bile secretion |
[1] CA2 | D00218 | Acetazolamide | [6] 13, 90, 115, 155, 225, 230 |
| D01196 | |||||
| 3 | Breast cancer |
[2] ESR1, PGR | D02367 | Desogestrel | [1] 230 |
| 4 | cAMP signaling pathway |
[1] DRD2 | D01745 | Domperidone | [5] 6, 13, 17, 51, 230 |
| D07868 | |||||
| 5 | Cocaine addiction |
[1] DRD2 | D01745 | Domperidone | [5] 6, 13, 17, 51, 230 |
| D07868 | |||||
| 6 | Collecting duct acid secretion |
[1] CA2 | D00218 | Acetazolamide | [6] 13, 90, 115, 155, 225, 230 |
| D01196 | |||||
| 7 | Dopaminergic synapse |
[1] DRD2 | D01745 | Domperidone | [5] 6, 13, 17, 51, 230 |
| D07868 | |||||
| 8 | Endocrine and other factor-regulated calcium reabsorption |
[1] ESR1 | D02367 | Desogestrel | [1] 230 |
| 9 | Endocrine resistance |
[1] ESR1 | D02367 | Desogestrel | [1] 230 |
| 10 | Estrogen signaling pathway |
[2] ESR1, PGR | D02367 | Desogestrel | [1] 230 |
| 11 | Gap junction |
[1] DRD2 | D01745 | Domperidone | [5] 6, 13, 17, 51, 230 |
| D07868 | |||||
| 12 | Gastric acid secretion |
[1] CA2 | D00218 | Acetazolamide | [6] 13, 90, 115, 155, 225, 230 |
| D01196 | |||||
| 13 | Metabolic pathways |
[13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 | D00218 | Acetazolamide | [6] 13, 90, 115, 155, 225, 230 |
| D01196 | |||||
| 14 | Neuroactive ligand-receptor interaction |
[1] DRD2 | D01745 | Domperidone | [5] 6, 13, 17, 51, 230 |
| D07868 | |||||
| 15 | Nitrogen metabolism |
[13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 | D00218 | Acetazolamide | [6] 13, 90, 115, 155, 225, 230 |
| D01196 | |||||
| 16 | Oocyte meiosis |
[1] PGR | D02367 | Desogestrel | [1] 230 |
| 17 | Pancreatic secretion |
[1] CA2 | D00218 | Acetazolamide | [6] 13, 90, 115, 155, 225, 230 |
| D01196 | |||||
| 18 | Parkinson disease |
[1] DRD2 | D01745 | Domperidone | [5] 6, 13, 17, 51, 230 |
| D07868 | |||||
| 19 | Pathways in cancer |
[1] ESR1 | D02367 | Desogestrel | [1] 230 |
| 20 | Progesterone-mediated oocyte maturation |
[1] PGR | D02367 | Desogestrel | [1] 230 |
| 21 | Prolactin signaling pathway |
[1] ESR1 | D02367 | Desogestrel | [1] 230 |
| 22 | Proteoglycans in cancer |
[1] ESR1 | D02367 | Desogestrel | [1] 230 |
| 23 | Proximal tubule bicarbonate reclamation |
[2] CA2, CA4 | D00218 | Acetazolamide | [6] 13, 90, 115, 155, 225, 230 |
| D01196 | |||||
| 24 | Rap1 signaling pathway |
[1] DRD2 | D01745 | Domperidone | [5] 6, 13, 17, 51, 230 |
| D07868 | |||||
| 25 | Thyroid hormone signaling pathway |
[1] ESR1 | D02367 | Desogestrel | [1] 230 |